BIOPHARMADIVE

BiopharmaDive provides in-depth news and analysis on the biopharmaceutical industry, covering the latest developments in drug research, regulatory changes, and market trends.

Latest News:

• Braveheart secures $185M to advance challenger to Bristol Myers heart drug
• Blackstone pays Merck $700M to buy into ADC drug royalties
• Metsera again chooses Novo as bidding war with Pfizer intensifies
• Vertex’s new pain, blood disorder drugs miss Wall Street expectations
• Sarepta Duchenne drugs come up short in confirmatory test
• Neok Bio launches with $75M to make dual-targeting ADCs
• UniQure dives after FDA’s ‘very surprising’ reversal on Huntington’s gene therapy